概述

  • 产品名称Anti-FLJ23834抗体
    参阅全部 FLJ23834 一抗
  • 描述
    小鼠单克隆抗体to FLJ23834
  • 经测试应用适用于: WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Recombinant fragment, corresponding to amino acids 776-886 of Human FLJ23834

性能

应用

Our Abpromise guarantee covers the use of ab56549 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB
  • 应用说明WB: Use at a concentration of 1-5 µg/ml.

    This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能Cadherins are calcium dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.
    • 序列相似性Contains 6 cadherin domains.
    • 细胞定位Cell membrane.
    • Information by UniProt
    • 数据库链接
    • 别名
      • Cadherin-like protein 28 antibody
      • Cadherin-related family member 3 antibody
      • Cdhr3 antibody
      • CDHR3_HUMAN antibody
      • FLJ43271 antibody
      • Hypothetical protein FLJ23834 antibody
      • Hypothetical protein LOC222256 antibody
      • MGC133292 antibody
      • MGC133293 antibody
      see all

    Anti-FLJ23834 antibody 图像

    • Western blot against tagged recombinant protein immunogen using ab56549 FLJ23834 antibody at 1ug/ml. Predicted band size of immunogen is 38 kDa

    Anti-FLJ23834 antibody (ab56549)参考文献

    ab56549 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab56549.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"